TY - BOOK ID - 133707491 TI - Clinical review report : (Sanofi Genzyme, a division of Sanofi-Aventis Canada Inc.) : indication : indicated for the treatment of adults with acquired thrombotic thrombocytopenic purpura (aTTP) in combination with plasma exchange (PEX) and immunosuppress PY - 2020 PB - Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health, DB - UniCat KW - Plasma exchange (Therapeutics) UR - https://www.unicat.be/uniCat?func=search&query=sysid:133707491 AB - ER -